Hansa Biopharma AB (HNSBF)
3.65
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Hansa Biopharma 1 Year Total Returns (Daily): 21.67% for Nov. 13, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 13, 2024 | 21.67% |
November 12, 2024 | 21.67% |
November 11, 2024 | 21.67% |
November 08, 2024 | 21.67% |
November 07, 2024 | 21.67% |
November 06, 2024 | 21.67% |
November 05, 2024 | 21.67% |
November 04, 2024 | 21.67% |
November 01, 2024 | 21.67% |
October 31, 2024 | 21.67% |
October 30, 2024 | 21.67% |
October 29, 2024 | 21.67% |
October 28, 2024 | 21.67% |
October 25, 2024 | 21.67% |
October 24, 2024 | 21.67% |
October 23, 2024 | 21.67% |
October 22, 2024 | 21.67% |
October 21, 2024 | -2.33% |
October 18, 2024 | -2.33% |
October 17, 2024 | -2.33% |
October 16, 2024 | -2.33% |
October 15, 2024 | -2.33% |
October 14, 2024 | -2.33% |
October 11, 2024 | -2.33% |
October 10, 2024 | -2.33% |
Date | Value |
---|---|
October 09, 2024 | -2.33% |
October 08, 2024 | -2.33% |
October 07, 2024 | -2.33% |
October 04, 2024 | -2.33% |
October 03, 2024 | -2.33% |
October 02, 2024 | -25.45% |
October 01, 2024 | -25.45% |
September 30, 2024 | -25.45% |
September 27, 2024 | -25.45% |
September 26, 2024 | -25.45% |
September 25, 2024 | -25.45% |
September 24, 2024 | -25.45% |
September 23, 2024 | -25.45% |
September 20, 2024 | -25.45% |
September 19, 2024 | -25.45% |
September 18, 2024 | -25.45% |
September 17, 2024 | -25.45% |
September 16, 2024 | -25.45% |
September 13, 2024 | -25.45% |
September 12, 2024 | -25.45% |
September 11, 2024 | -25.45% |
September 10, 2024 | -25.45% |
September 09, 2024 | -25.45% |
September 06, 2024 | -25.45% |
September 05, 2024 | -25.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-76.81%
Minimum
Dec 17 2019
112.5%
Maximum
Oct 07 2020
-22.62%
Average
-38.38%
Median
Jul 31 2024
1 Year Total Returns (Daily) Benchmarks
Abliva AB | 0.00% |
Oncopeptides AB | -55.83% |
BioInvent International AB | 0.00% |
BioArctic AB | -30.85% |
Camurus AB | -- |